GLP1-S (Semaglutide)
Price Range
$7.50 – $58.50/mg
Vendors
11
Views
123
Where to Buy
Compare GLP1-S (Semaglutide) prices across verified vendors. Affiliate links support Pushing Peptides.
| $4.00 | 20mg | $80.00 |
Price/mg
$4.00
Vial
20mg
Price
$80.00
| Vendor | Price/mg | Vial Size | Price/Vial | |
|---|---|---|---|---|
Instant PeptidesVerified | $11.60 | 5mg | $58.00 | View |
| $7.50 | 10mg | $75.00 | ||
| $10.00 | 5mg | $49.99 | ||
| $12.00 | 5mg | $59.99 | ||
| $58.50 | 10mg | $585.00 |
Price/mg
$7.50
Vial
10mg
Price
$75.00
Price/mg
$10.00
Vial
5mg
Price
$49.99
Price/mg
$12.00
Vial
5mg
Price
$59.99
Price/mg
$58.50
Vial
10mg
Price
$585.00
Overview
Semaglutide, listed as GLP1-S in research vendor catalogs, is a GLP-1 receptor agonist with structural modifications that extend its half-life to approximately one week. It is one of the most studied peptides in the metabolic research space, with extensive clinical trial data supporting its effects on weight management and glycemic control.
Mechanism of Action
Semaglutide binds to and activates the GLP-1 receptor with high affinity. An acylated fatty acid chain enables albumin binding, dramatically extending circulatory half-life. GLP-1 receptor activation in the hypothalamus reduces appetite and food intake. Peripheral effects include slowed gastric emptying, enhanced insulin secretion, and suppressed glucagon release.
Research Context
Clinical trials demonstrated significant weight reduction (up to 15-17% of body weight) in study participants. Semaglutide also showed cardiovascular benefits including reduced major adverse cardiovascular events. It is one of the most commercially successful peptide therapeutics in history.
Key Research Areas
Considerations for Researchers
Due to its commercial pharmaceutical status, research-grade semaglutide from peptide vendors differs from pharmaceutical products. Verify purity and identity through independent testing. Store lyophilized at -20C.
Learn more about GLP1-S (Semaglutide)
Research articles and guides
GLP1-S (Semaglutide) Latest Research & Clinical Trial Updates
Explore how GLP1-S (Semaglutide) is transforming weight loss research, with highlights from the latest clinical studies and findings.
Semaglutide Cardiovascular Research: Beyond Weight Management
Semaglutide, a well-studied GLP-1 receptor agonist, has generated significant interest in the research community for its robust effects on cardiovascular outcomes, beyond its more widely recognized ro.
Semaglutide vs Tirzepatide vs Retatrutide: Incretin Peptide Comparison
The field of metabolic and obesity research has seen a dramatic evolution with the emergence of incretin-based peptide therapies. As researchers seek to understand mechanisms of energy balance, glucos.
Disclaimer: All information on this page is for research purposes only and is not intended as medical advice. Peptide research should be conducted by qualified professionals in appropriate laboratory settings. Pushing Peptides does not sell peptides. We aggregate publicly available pricing and vendor data.